Search
for
Sort by
Research 30 of 1000+
- Skin manifestations associated with systemic diseases – Part I
- Colchicine in Managing Skin Conditions: A Systematic Review
- Skin Manifestations of Rheumatological Diseases
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Issue Information
- General Dermatology
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- Dermatologic therapy: December 1987 to December 1988
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Skin signs of systemic diseases
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Skin
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Cosmeceuticals in Dermatology
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
- Erosive Pustular Dermatosis of the Scalp: Clinicopathological Correlation Leading to a Definition of Diagnostic Criteria
- A Case Report of Granuloma Faciale of the Scalp Arising in the Setting of Advanced Androgenetic Alopecia With a Review of Extrafacial Granuloma Faciale Occurring on the Scalp
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
- SKIN MANIFESTATIONS OF RHEUMATOLOGICAL DISEASES
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Subject Index
- TONGUE, RED
- Author Index
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Perifollicular erythema as a trichoscopy sign of progression in frontal fibrosing alopecia
- <i>Urticaria Neonatorum:</i> Accumulation of tryptase‐expressing mast cells in the skin lesions of newborns with Erythema Toxicum
- Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study